Follow-up study of heart artery changes in familial high cholesterol
Part of Heart & circulation clinical trials.
This trial follows people with a genetic high-cholesterol condition (HeFH) who had a heart scan at least 5 years ago. Researchers will do a new scan to see how their heart arteries have changed over time, without any experimental treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a condition called heterozygous familial hypercholesterolemia (HeFH), which causes very high cholesterol.
- You are between 30 and 60 years old.
- You had a heart artery calcium score (CAC) and a CT scan of your heart arteries at least 5 years ago, and both were done at the same imaging center (ICT de la Pitié Salpetrière).
- You did not have chest pain with exercise at the time of that previous CT scan.
- You are not pregnant, breastfeeding, or have a severe allergy to contrast dye or other medical conditions that would make a CT scan risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called QLC7401 for people with a genetic condition called heterozygous familial hypercholesterolemia, which causes very high cholesterol. It aims to see if the new medicine can further lower bad cholesterol when added to your usual cholesterol treatments.
This observational study looks at how adding evinacumab to standard cholesterol-lowering therapy affects plaque in the heart arteries of people with homozygous familial hypercholesterolemia (HoFH). It compares those who started evinacumab within the last 2 years to those on standard therapy alone, using CT scans taken before and after treatment.
This study uses a heart CT scan to look for plaque buildup in the arteries of people with familial hypercholesterolemia (a genetic high-cholesterol condition). It aims to understand why some people with FH develop heart disease while others don't.
This study looks at people with coronary artery disease (narrowed or blocked heart arteries) to see how different imaging and function tests can help predict outcomes. If you've had a heart procedure or test showing blockages, you might be eligible.
This trial tests a new CT scanner (photon-counting CT) combined with a tiny camera inside the heart arteries to better see blockages. It's for people with chest pain or silent ischemia, but not for those having a big heart attack (STEMI) or with unstable conditions.
This study tests a new injection called ART002g1 for people with an inherited form of high cholesterol (heterozygous familial hypercholesterolemia). The goal is to see if it is safe and can help lower cholesterol levels.
Hear when a new Heterozygous Familial Hypercholesterolemia (HeFH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.